Leading the Site CTMS Market: Clinical Conductor CTMS Reaches 1,600 Sites

Rochester, NY – August 29, 2013 – Bio-Optronics, the developer of Clinical Conductor Site CTMS, is thrilled to announce the successful CTMS implementation at over 1,600 clinical research sites around the world, making it the most widely-used clinical trial management system. Designed specifically for research sites, Clinical Conductor Site CTMS is the premier tool for clinical research sites.

Sites that have adopted the Clinical Conductor Site CTMS platform have seen dramatic improvements in their overall operational effectiveness; many sites have reported up to a 20% increase in overall efficiency, while showing a 30% increase in profitability while using the software.

Company Vice President and CBO Maria Durkin states, “Clinical Conductor Site CTMS has revolutionized the way sites conduct trials. Our customers are meeting recruitment targets more quickly, improving financial performance and managing trial documentation efficiently.  Sites using Clinical Conductor are also differentiating themselves as successful research organizations that consistently meet deliverables and achieve results. We’ve seen our customers achieve significant growth in trials. We are proud to be working with them and appreciate the ongoing feedback that enables Clinical Conductor Site CTMS to continue to adapt and grow with the market’s needs.”

Clinical Conductor Site CTMS has helped research sites worldwide make a profound impact on the healthcare industry. Since its debut, Clinical Conductor Site CTMS has been used in nearly 40,000 trials and has tracked over 2 million trial patients, spanning single sites, multi-location sites, site networks and hospital departments. As Clinical Conductor Site CTMS continues to grow, we foresee additional ways in which researchers will be able to expand and optimize their businesses, while expediting delivery of critical new enhancements in medicine, through the use of this CTMS.

Created with the understanding that no two sites are the same, Clinical Conductor Site CTMS has been designed with extensive functionality capable of satisfying every trial management need while adapting to the specific needs of each research organization. Listening to our customers and adapting to their changing needs, coupled with many years of healthcare experience, Clinical Conductor is able to stay on the leading edge when it comes to providing research organizations the necessary tools for successful trial management. The success and experience with site customers has provided Bio-Optronics the knowledge to expand its portfolio with Clinical Conductor Enterprise, a unique CTMS that provides unparalleled project management, visibility and real-time collaboration for CROs, SMOs, AMCs and provider networks managing multiple research trials across multiple sites, research organizations and partners.

Clinical Conductor Site CTMS is the site-specific trial management solution from leading healthcare software and service provider Bio-Optronics. As a market leader with over 28 years of industry experience working with over 1,800 healthcare and life sciences organizations, Bio-Optronics produces a variety of products aimed at meeting the specific needs of each organization: Clinical Conductor Enterprise, a leading-edge CTMS for organizations managing multiple trials across multiple locations; Momentum Physician and Staff Scheduler,  the highly configurable, rule-based scheduling software; and Biopoint, a patient identification system designed to ensure the proper identification of patients and synchronization of treatment at hospitals and other long-term care facilities. Bio-Optronics and its products are recognized for consistent, unparalleled service and support that continuously ensures our products are exceeding client and market needs.

Bio-Optronics, +1 585-272-1960, www.bio-optronics.com; Kyle Ricketts, Marketing Specialist, kricketts@bio-optronics.com